Home › Research › Clinical trials
Clinical trials
Every Alzheimer's trial in our copy of the ClinicalTrials.gov registry — completed, running and abandoned. Filter it, then follow the link to the official record.
If you are thinking about joining a trial
A listing here is a record that a study was registered. It is not a recommendation, and it does not mean the study is still recruiting or that anyone is eligible. Registry entries go stale.
Talk to the treating doctor first, then contact the study team listed on the official ClinicalTrials.gov record. The NIA's free referral line can help you look: 1-800-438-4380, weekdays, English and Spanish.
Showing 901–925 of 7,816 matching trials · page 37 of 313, 25 per page.
Sorted by the date the registry record was last updated, newest first. This page never loads all 7,816 rows at once — use the CSV download if you want the whole file.
| Trial | Phase | Status | Enrolled | Sponsor | Last updated |
|---|---|---|---|---|---|
|
Communication Bridge 3 Study NCT06191198 Communication Bridge™; Evidence-Based Impairment Focused Runs in: United States · 1 site |
PHASE2 other |
RECRUITING | 200 | University of Chicago OTHER |
2026-06-01 |
|
Reducing Burden in Care Partners of Community-Dwelling Persons With Dementia and Oropharyngeal Dysphagia NCT06557863 WeCareToFeedDysphagia web tool Runs in: United States · 1 site |
NA other |
COMPLETED | 80 | Northwell Health OTHER |
2026-06-01 |
|
Train Your Brain Fitness SC: An Exercise Intervention for People With Cognitive Impairments NCT06799429 Supervised Exercise and Behavior Modification Support; Monitored Ex... Runs in: United States · 2 sites |
NA other |
RECRUITING | 50 | University of South Carolina OTHER |
2026-06-01 |
|
Intranasal Dexmedetomidine-esketamine on Sleep and Cognition in Older Adults With Mild-to-moderate Cognitive Impairment NCT07610343 Dexmedetomidine-esketamine combination; Placebo Runs in: China · 1 site |
PHASE4 other |
NOT_YET_RECRUITING | 60 | Peking University First Hospital OTHER |
2026-06-01 |
|
Phase 2 - Rhythmic Light Therapy for Alzheimer's Disease Patients NCT05016219 Circadian-Effective Light; Rhythmic Light; Placebo Light; Placebo R... Runs in: United States · 2 sites |
NA other |
RECRUITING | 120 | Icahn School of Medicine at Mount Sinai OTHER |
2026-05-29 |
|
Smartphone-based Cognitive Emotion Regulation Training for Unpaid Primary Caregivers of Persons With Alzheimer's Disease NCT05949047 Cognitive Emotion Regulation Training via Psychological Distancing;... Runs in: United States · 1 site |
NA other |
RECRUITING | 270 | Bryan Denny OTHER |
2026-05-29 |
|
The Nuestros Días ("Our Days") Study NCT06475534 Runs in: United States · 1 site |
NA other |
ACTIVE_NOT_RECRUITING | 300 | University of Alabama at Birmingham OTHER |
2026-05-29 |
|
Tailored Brain Health Insights Through Nurturing Knowledge-based Change - Stakeholder-driven, Human-centered, AI-powered Refinement for Prevention NCT07612800 BLAZE (Brain health Lifestyle Action with personaliZed Engagement) Runs in: Singapore · 1 site |
NA other |
NOT_YET_RECRUITING | 350 | Alexandra Hospital OTHER |
2026-05-29 |
|
Comparison of AI-based Smartphone-derived Gait Parameters With the Gold Standard NCT07613957 Gait analysis via vicon- and app-system |
NA other |
NOT_YET_RECRUITING | 40 | Technical University of Munich OTHER |
2026-05-29 |
|
Evaluation of the Impact of Virtual Park on Training Motivation in Adult Patients NCT07616050 Dual-task training with Virtual Reality; Cycling training Runs in: Italy · 7 sites |
NA other |
NOT_YET_RECRUITING | 70 | Marta Mondellini OTHER |
2026-05-29 |
|
Subjective Assessment of Spatial Orientation Abilities in Alzheimer's Disease NCT07616063 Questionnaire d'Orientation Spatiale (QOS) Runs in: France · 1 site |
NA other |
NOT_YET_RECRUITING | 330 | Central Hospital, Nancy, France OTHER |
2026-05-29 |
|
Motor Slowing and Its Lesion-related Correlates in Alzheimer's Disease NCT02811653 Brain MRI; neuropsychological evaluation; Blood Runs in: France · 1 site |
NA other |
RECRUITING | 155 | Centre Hospitalier Universitaire, Amiens OTHER |
2026-05-28 |
|
Multi-Center Development of a Novel Diagnostic Test for Alzheimer's Disease NCT03560960 Pramlintide challenge test Runs in: United States · 3 sites |
EARLY_PHASE1 other |
ACTIVE_NOT_RECRUITING | 57 | Boston University OTHER |
2026-05-28 |
|
Alzheimer's Disease Stem Cells Multiple Infusions NCT04040348 Approximately 100 million cells allogeneic hMSC Runs in: United States · 1 site |
PHASE1 other |
COMPLETED | 6 | Bernard (Barry) Baumel OTHER |
2026-05-28 |
|
Locus-coeruleus Function in Normal Elderly and AD Risk NCT04403165 Nocturnal polysomnography (NPSG); Lumbar Puncture (LP); PET-MR meas... Runs in: United States · 2 sites |
NA other |
COMPLETED | 30 | NYU Langone Health OTHER |
2026-05-28 |
|
A Study of Caregiver Connections Via Technology in Dementia NCT05779839 Algorithm; Random Match Runs in: United States · 1 site |
NA other |
ACTIVE_NOT_RECRUITING | 355 | Mayo Clinic OTHER |
2026-05-28 |
|
PRogram to Improve Stress-levels and Enhance Memory NCT05845918 PRISEM Remote Runs in: United States · 2 sites |
NA other |
COMPLETED | 45 | Emory University OTHER |
2026-05-28 |
|
The INSPIRE -Faith Study: Intervention Strategies for Preserving Intellectual Resilience and Engagement NCT06741865 Lifestyle Intervention; Standard Health Education Runs in: United States · 1 site |
NA other |
RECRUITING | 2,000 | Healthy Minds Initiative OTHER |
2026-05-28 |
|
Human Mesenchymal Stem Cells (hMSC) in Behavioral Problems Due to Alzheimer's Disease. NCT06781333 hMSC Runs in: United States · 1 site |
PHASE2 other |
RECRUITING | 8 | Bernard (Barry) Baumel OTHER |
2026-05-28 |
|
A BCT Intervention for an Hourly Activity Habit Among Caregivers for Persons With AD/ADRD NCT06801912 Behavior Change Technique Package Runs in: United States · 1 site |
NA other |
COMPLETED | 100 | Northwell Health OTHER |
2026-05-28 |
|
Expanded Access Program for CT1812 (Zervimesine) NCT06961760 zervimesine Runs in: United States · 8 sites |
NA other |
NO_LONGER_AVAILABLE | — | Cognition Therapeutics INDUSTRY |
2026-05-28 |
|
Human Mesenchymal Stem Cells & Monoclonal Antibodies in the Treatment for Mild Cognitive Impairment or Early Alzheimer's Disease. NCT07512362 human Mesenchymal Stem Cells Runs in: United States · 1 site |
PHASE2 other |
RECRUITING | 10 | Bernard (Barry) Baumel OTHER |
2026-05-28 |
|
Early Molecular Biomarkers for Differentiating Parkinsonian Syndromes NCT07604883 Runs in: Poland · 2 sites |
NA other |
NOT_YET_RECRUITING | 200 | International Institute of Molecular and Cell Biology in Warsaw OTHER_GOV |
2026-05-28 |
|
[18F]F-AraG PET Imaging in Alzheimer's Disease NCT07611357 Drug: [18F]F-AraG (PET tracer) |
PHASE2 other |
NOT_YET_RECRUITING | 10 | CellSight Technologies, Inc. INDUSTRY |
2026-05-28 |
|
A Study to Evaluate the Safety, Tolerability, and Efficacy of TML-6 in Participants With Early Alzheimer's Disease NCT07612150 TML-6; Placebo |
PHASE2 other |
NOT_YET_RECRUITING | 210 | Merry Life Biomedical Co., Ltd. INDUSTRY |
2026-05-28 |
This table is wider than a phone screen — swipe it sideways to see the rest.
Where these trials come from
- Registry
- ClinicalTrials.gov, pulled through their public API (v2)
- Trials in the file
- 7,816
- Source file
- trials.csv (3.8 MB, 7816 rows)
- Basis
- Measured These are registry records as submitted by each study's sponsor.
What could make this misleading
Sponsors enter their own data and do not always keep it current, so "recruiting" can be out of date by months or years. Enrollment figures may be targets rather than actual numbers; the downloaded file says which for each trial. Trials that were never registered do not appear at all, and the intervention class is this project's own grouping, not the registry's.
Always check the official record before acting on anything here. This is a summary, not medical advice.
From the research library
The highest-scoring studies we hold on this subject, each summarised in plain English. Scores are alzhub's usefulness score, not a verdict on the science.
Clinical trials
- MINocyclinE to Reduce inflammation and blood-brain barrier leakage in small Vessel diseAse (MINERVA): A phase II, randomized, double-blind, placebo-controlled experimental medicine trial
- Safety and efficacy of crenezumab in cognitively unimpaired carriers of the PSEN1Glu280Ala mutation at risk for autosomal-dominant Alzheimer's disease in Colombia (API ADAD Colombia Trial): a phase 2, randomised, double-blind, placebo-controlled trial
- Study of mirtazapine for agitated behaviours in dementia (SYMBAD): a randomised, double-blind, placebo-controlled trial
- Randomized, double-blind study of zervimesine in mild to moderate Alzheimer's disease
- Efficacy assessment of an active tau immunotherapy in Alzheimer's disease patients with amyloid and tau pathology: a post hoc analysis of the "ADAMANT" randomised, placebo-controlled, double-blind, multi-centre, phase 2 clinical trial